Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1176 | 1007 | 1176 | 1246 | 1546 | 2163 |
Fund Return | 17.56% | 0.74% | 17.56% | 7.59% | 9.11% | 8.02% |
Place in category | 28 | 41 | 28 | 36 | 48 | 57 |
% in Category | 2 | 3 | 2 | 2 | 3 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPM Global Income Fund A Mth EUR | 17.72B | 6.39 | -1.14 | - | ||
JPMorgan Global Income D div EUR | 17.72B | 6.03 | -1.46 | 1.72 | ||
JPM Global Income A acc EUR | 17.72B | 6.40 | -1.12 | 2.08 | ||
LU0740858492 | 17.72B | 6.02 | -1.47 | 1.72 | ||
JPMorgan Global Income A Div EUR | 17.72B | 6.40 | -1.12 | 2.08 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A DIST Eue | 6.88B | 15.73 | 4.38 | 5.61 | ||
European Growth Fund A Acc EUR | 167.82M | 15.77 | 4.40 | 5.61 | ||
European Growth Fund E Acc EUR | 22.77M | 14.87 | 3.61 | 4.82 | ||
European Growth Fund Y Acc EUR | 265.1M | 16.70 | 5.28 | 6.49 | ||
European Growth Fund Y DIST EUR | 67.61M | 16.70 | 5.28 | 6.49 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPMorgan Liquidity Funds Euro Liquidity Fund X ( | LU0836346931 | 6.49 | 10,594.580 | +0.01% | |
SAP | DE0007164600 | 2.99 | 268.950 | +0.34% | |
Roche Holding Participation | CH0012032048 | 2.91 | 285.20 | +0.00% | |
Novartis | CH0012005267 | 2.44 | 93.80 | +0.00% | |
Novo Nordisk B | DK0062498333 | 2.25 | 612.8 | +1.51% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review